Bispecific antibody targeting CD40 and HER2 potentiates therapeutic efficacy by reprogramming macrophages within the tumour microenvironmentNa Li, Ruonan Li, Qiongqiong Ma et al.|Clinical and Translational Medicine|2025Cited by 0